CoronavirusCovid-19Health

Moderna Says COVID Vaccine 100% Effective in Teens, Will Seek FDA Approval in June

Moderna announced Tuesday its coronavirus vaccine was 100% effective in a study of adolescents ages 12 to 17 and will seek emergency use approval from the Food and Drug Administration early next month.

The drugmaker’s vaccine, if approved would be the second behind the Pfizer/BioNTech vaccine to get clearance for use in adolescents.

The Moderna study covered more than 3,700 adolescents. No cases of the virus were observed in the participants who received two doses of the vaccine, while four cases were seen in the placebo group, the company said.

Additionally, no significant side effects were identified among the participants that were not uncommon to adults, the company said.

“We are encouraged that mRNA-1273 was highly effective at preventing COVID-19 in adolescents,” Moderna CEO Stephane Bancel said in a statement. “We remain committed to doing our part to help end the COVID-19 pandemic.”

The two-dose Pfizer/BioNTech vaccine, the first to come out for adults in December, was cleared for 12-to-15-year-olds earlier this month.

Show More

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *


By submitting this form, you are consenting to receive marketing emails from: Washington Informer Newspaper, 3117 Martin Luther King Jr. Ave SE, Washington, DC, 20032, http://www.washingtoninformer.com. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Back to top button

My News Matters to me - Washington Informer Donations

Be a Part of The Washington Informer Legacy

A donation of your choice empowers our journalists to continue the work to better inform, educate and empower you through technology and resources that you use.

Click Here Today to Support Black Press and be a part of the Legacy!

Subscribe today for free and be the first to have news and information delivered directly to your inbox.

Select list(s) to subscribe to


By submitting this form, you are consenting to receive marketing emails from: Washington Informer Newspaper, 3117 Martin Luther King Jr. Ave SE, Washington, DC, 20032, http://www.washingtoninformer.com. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact
Close

Adblock Detected

Please consider supporting us by disabling your ad blocker